Medicaid
Commentary
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
Commentary
Myth of the Massachusetts Health-Insurance Mandate
David Leonhardt asserts that: “…the law depends to a significant degree on the mandate. Without it, some healthy people will wait to buy coverage until they get sick — which, of course, is not an insurance system at all. It’s free-riding. Just look at Massachusetts. In 1996, it barred insurers ...
Commentary
The Fatal Move From The FDA
On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country’s most deadly diseases. Avastin, an advanced treatment for late-stage breast cancer, made it through the FDA approval process back in ...
Commentary
If Obamacare is Unconstitutional, Why Aren’t Medicare & Medicaid?
Legally, the difference is that the latter two programs are government operations, whereas the individual mandate would have compelled people to buy a private product. Helvering v. Davis (1937) was the famous (or infamous) case wherein the U.S. Supreme Court found that the Social Security Act was constitutional. For a ...
Commentary
Blue-Sky Thinking on Health Reform: An Interstate Compact for Health Insurance
Key Points Health insurance is the only line of insurance regulated by the federal government, but federal control has created and deepened the health crisis. Obamacare attempts to conscript states to do the dirty work of limiting peoples choice of health benefits. States have ensured portability and competition in other ...
Commentary
U.S. competitive without medical monopoly
The November election made a bull’s-eye out of Obamacare, which some Republicans want to repeal. Obamacare is a worthy target because it is a significant lurch toward so-called “universal” health care. The lack of such a government monopoly system, some charge, harms American competitiveness. But that argument fails to hold ...
Commentary
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
Commentary
Are Your State Politicians Serious About Defeating Obamacare? A “Litmus Test”
Last months elections demonstrated convincingly that the American people are already fed up with Obamacare, the March legislation that gives the federal government control over our access to medical services. Anti-Obamacare Republicans took the majority in the House of Representatives and increased their numbers in the U.S. Senate. Most people ...
Commentary
Reform Fails To Fix Uninsured Problem
The Centers for Disease Control and Prevention just announced that 59.1 million Americans went without health insurance for at least part of this year an all-time high. The CDC estimate comes on the heels of a report from the Census Bureau that arrived at a similar conclusion. Supporters of ...
Commentary
Obamacare ‘Rule,’ 347 Pages, 118,072 Words
This “rule” (that’s what they call it) was signed by HHS secretary Kathleen Sebelius and by Medicare administrator Donald Berwick, who — as the Medical News reports — “will testify before a congressional committee [today] for the first time since President Barack Obama avoided the Senate confirmation process” in appointing ...
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
Myth of the Massachusetts Health-Insurance Mandate
David Leonhardt asserts that: “…the law depends to a significant degree on the mandate. Without it, some healthy people will wait to buy coverage until they get sick — which, of course, is not an insurance system at all. It’s free-riding. Just look at Massachusetts. In 1996, it barred insurers ...
The Fatal Move From The FDA
On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country’s most deadly diseases. Avastin, an advanced treatment for late-stage breast cancer, made it through the FDA approval process back in ...
If Obamacare is Unconstitutional, Why Aren’t Medicare & Medicaid?
Legally, the difference is that the latter two programs are government operations, whereas the individual mandate would have compelled people to buy a private product. Helvering v. Davis (1937) was the famous (or infamous) case wherein the U.S. Supreme Court found that the Social Security Act was constitutional. For a ...
Blue-Sky Thinking on Health Reform: An Interstate Compact for Health Insurance
Key Points Health insurance is the only line of insurance regulated by the federal government, but federal control has created and deepened the health crisis. Obamacare attempts to conscript states to do the dirty work of limiting peoples choice of health benefits. States have ensured portability and competition in other ...
U.S. competitive without medical monopoly
The November election made a bull’s-eye out of Obamacare, which some Republicans want to repeal. Obamacare is a worthy target because it is a significant lurch toward so-called “universal” health care. The lack of such a government monopoly system, some charge, harms American competitiveness. But that argument fails to hold ...
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
Are Your State Politicians Serious About Defeating Obamacare? A “Litmus Test”
Last months elections demonstrated convincingly that the American people are already fed up with Obamacare, the March legislation that gives the federal government control over our access to medical services. Anti-Obamacare Republicans took the majority in the House of Representatives and increased their numbers in the U.S. Senate. Most people ...
Reform Fails To Fix Uninsured Problem
The Centers for Disease Control and Prevention just announced that 59.1 million Americans went without health insurance for at least part of this year an all-time high. The CDC estimate comes on the heels of a report from the Census Bureau that arrived at a similar conclusion. Supporters of ...
Obamacare ‘Rule,’ 347 Pages, 118,072 Words
This “rule” (that’s what they call it) was signed by HHS secretary Kathleen Sebelius and by Medicare administrator Donald Berwick, who — as the Medical News reports — “will testify before a congressional committee [today] for the first time since President Barack Obama avoided the Senate confirmation process” in appointing ...
